Screening of staff for MRSA in a university hospital department of surgery;MRSA-personalscreening in einer chirurgischen universitätsklinik

Hygiene + Medizin

Volumn 34, Issue 5, 2009, Pages 183-187

  Joos, Andreas K ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Dickdarmzentrum Mannheim ^*  (Germany)

Author keywords

MRSA; Screening; Staff

Indexed keywords

EID: 67650491245     PISSN: 01723790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA, Paul-Ehrlich-Society for Chemotherapy. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis. Int J Antimicrob Agents 2004; 23:577-81.
2. Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;46:43-49.
3. Simor AE, Ofner-Agostini M, Bryce E, Green K, Mc-Geer A, Mulvey M, Paton S. Canadian Nosocomial Infection Surveillance Program, Health Canada. CMAJ 2001; 165:21-26.
4. Gould IM, MacKenzie FM, MacLennan G, Pacitti D, Watson EJ, Noble DW. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in am intensive care unit. Int J Antimicrob Agents 2007; 29:536-43.
5. Harbarth S, Dharan S, Liassine N, Herrault P, Auckentahler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of Mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43:1412-16.
6. Kampf G, Kramer A. Eradication of methicillinresistant Staphylococcus aureus with an antiseptic soap and nasal mupirocin among colonized patients - an open uncontrolles clinical trial. Ann Clin Microbiol Antimicrob 2004; 3:9.
7. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus. JAMA 1999; 282:1745-51.
8. Diller R, Sonntag AK, Mellmann A, Grevener K, Senninger N, Kipp F, Friedrich A. Evidence for cost reduction based on pre-admission MRSA screening in general surgery. Int J Hyg Environ Health 2008; 211:205-12.
9. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, Piatt R. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillinresistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006; 43:971-78.
10. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectivness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002; 51:126-32.
11. Lucet JC, ChevretS, Durand-Zaleski I, Chastang C, Regnier B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003; 163:181-88.
12. Allen KD, Anson JJ, Parsons LA, Frost NG. Staff carriage of methicillin-resistant Staphylococcus aureus and the home environment: a case report. J Hosp Infect 1997; 35:307-11.
13. Nulens E, Gould I, MacKenzie F, Deplano A, Cookson B, Alp E, Bouza E, Voss A. Staphylococcus aureus carriage among participants atthe 13th european congress of clinical microbiology and infectious disease. Eur J Clin Microbiol Infect Dis 2005;24:145-48.
14. Tammelin A, Klötz F, Hambraeus A, Stäble E, Ransjö U. Nasal and hand carriage of Staphylococcus aureus in staff at a department for thoracic and cardiovascular surgery: endogenous or exogenous source? Infect Control Hosp Epidemiol 2003; 24: 686-89.
15. RKI-Ratgeber Infektionskrankheiten - Merkblätter für ärzte. Robert Koch-Institut 2003; 1-13.
16. Arbeitskreis Krankenhaus-und Praxishygiene der AWMF. Maßnahmen beim Auftreten multiresistenter Erreger (MRE). Hygiene in Klinik und Praxis, 3. Auflage, mhp-Verlag, Wiesbaden 2004, S.121ff.
17. Kommission für Krankenhaushygiene und Infektionsprävention. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus-aureus-Stämmen (MRSA) in Krankenhausern und anderen medizinischen Einrichtungen. Bundesgesundheitsblatt-Gesundheitsforschung- Gesundheitsschutz 1999; 42:954-58.
18. Kunori T, Cookson B, Roberts JA, Stone S, Kibbler C. Cost-effectivness of different MRSA screening methods. J Hosp Infect 2002; 51:189-200.
19. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemilogy, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-20.
20. Eveillard M, Martin Y, Hidri N, Boussougant Y, Joly-Guillou ML. Carriage of methicillin-resistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol 2004; 25:114-20.
21. Lessing MP, Jordens JZ, Bowler IC. When should healthcare workers be screened for methicillinresistant Staphylococcus aureus. J Hosp Infect 1996;34:205-10.
22. Robert Koch Institut. Kontrolle der Weiterverbreitung von MRSA-Personal im Gesundheitsdienst als Carrier. RKI: Epidemiologisches Bulletin 36-2008. Epid Bull 2008; 36:303-11.